US industry welcomes government help on bioterror diagnostics
This article was originally published in Clinica
Executive Summary
US government regulators are by and large making a major effort to help expedite the development of medical products that will improve detection, prevention and surveillance of bioterrorist attacks, US industry officials said last week.